Guido Fiorentini

Vita-Salute San Raffaele University, Mayo Clinic in Arizona

Papers

5

Total Citations

132

H-Index

4

About

Dr. Guido Fiorentini is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive techniques for complex liver diseases. His major contributions center on comparing the efficacy and safety of pure laparoscopic versus robotic-assisted liver resections, particularly through rigorous, multicentric propensity score-matched analyses. His landmark 2021 study, with 71 citations, stratified outcomes by surgical difficulty scores, providing crucial evidence that robotic assistance may offer advantages in more challenging resections. Beyond technique comparisons, Dr. Fiorentini has systematically evaluated minimally invasive approaches for hilar cholangiocarcinoma, a notoriously difficult cancer, and established benchmarks for minimally invasive left lateral sectionectomy across North America. He has also explored the role of these advanced techniques in treating polycystic liver disease, expanding surgical options for patients with rare conditions. With his work cited over 120 times, Dr. Fiorentini is shaping the global conversation on how to optimize surgical outcomes, reduce invasiveness, and define "textbook outcomes" in hepatobiliary surgery, making him a pivotal figure for students and researchers interested in the future of minimally invasive liver surgery.

Research Focus

Key Achievements

4
H-Index
5
Papers
132
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Pure laparoscopic versus robotic liver resections: Multicentric propensity score‐based analysis with stratification according to difficulty scores
71 citations · 2021
📈 Most Prolific Year: 2021 (3 Papers)
🤝 Key Collaborators: 35
🏛 Institutions: Vita-Salute San Raffaele University, Mayo Clinic in Arizona

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago